Literature DB >> 19915810

Travellers' diarrhoea - pros and cons of different prophylactic measures.

Angelika Wagner1, Ursula Wiedermann.   

Abstract

Travellers' diarrhoea is the most likely cause for disturbing travel arrangements. At an average, 30-40% of tourists are concerned, depending on the travel destination. Due to the high impact on the travellers' health this topic is still of utmost importance in travel medicine. A wide spectrum of enteropathogens can be accountable, with enterotoxigenic Escherichia coli being the major causing pathogen among other bacteria, parasites and viruses. Here we discuss advantages and disadvantages of different prophylactic measures against travellers' diarrhoea. The effectiveness but also the relevance of hygiene education, vaccination and antibiotic or probiotic application will be discussed in the context of the travellers' different risk profiles.

Entities:  

Mesh:

Year:  2009        PMID: 19915810     DOI: 10.1007/s00508-009-1228-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  48 in total

1.  Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?

Authors:  T Weinke; I Liebold; G D Burchard; N Frühwein; M P Grobusch; C Hatz; H Kollaritsch; H D Nothdurft; E Reisinger; B Rieke; Ch Schönfeld; R Steffen; A Stich
Journal:  Travel Med Infect Dis       Date:  2008-11       Impact factor: 6.211

Review 2.  Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.

Authors:  Tomas Jelinek; Herwig Kollaritsch
Journal:  Expert Rev Vaccines       Date:  2008-07       Impact factor: 5.217

3.  Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers.

Authors: 
Journal:  J Travel Med       Date:  1997-03-01       Impact factor: 8.490

4.  A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.

Authors:  David N Taylor; A Louis Bourgeois; Charles D Ericsson; Robert Steffen; Zhi-Dong Jiang; Jane Halpern; Robert Haake; Herbert L Dupont
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

Review 5.  Vaccines against traveler's diarrhoea and rotavirus disease - a review.

Authors:  Ursula Wiedermann; Herwig Kollaritsch
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

Review 6.  Travellers' diarrhoea.

Authors:  Charles D Ericsson
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

7.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Authors:  H Kollaritsch; H Holst; P Grobara; G Wiedermann
Journal:  Fortschr Med       Date:  1993-03-30

8.  Quinolone resistance among Shigella spp. isolated from travellers returning from India.

Authors:  L Mensa; F Marco; J Vila; J Gascón; J Ruiz
Journal:  Clin Microbiol Infect       Date:  2007-12-08       Impact factor: 8.067

9.  Passenger behaviors associated with norovirus infection on board a cruise ship--Alaska, May to June 2004.

Authors:  Marc-Andre R Chimonas; George H Vaughan; Zandra Andre; Jaret T Ames; Grant A Tarling; Suzanne Beard; Marc-Alain Widdowson; Elaine Cramer
Journal:  J Travel Med       Date:  2008 May-Jun       Impact factor: 8.490

10.  Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.

Authors:  Sarah A Frech; Herbert L Dupont; A Louis Bourgeois; Robin McKenzie; Jaime Belkind-Gerson; Jose F Figueroa; Pablo C Okhuysen; Norma H Guerrero; Francisco G Martinez-Sandoval; Juan Hm Meléndez-Romero; Zhi-Dong Jiang; Edwin J Asturias; Jane Halpern; Olga R Torres; Ana S Hoffman; Christina P Villar; Raniya N Kassem; David C Flyer; Bo H Andersen; Kazem Kazempour; Sally A Breisch; Gregory M Glenn
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

View more
  7 in total

Review 1.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

2.  Statement on Older Travellers: Committee to Advise on Tropical Medicine and Travel.

Authors:  K L McClean
Journal:  Can Commun Dis Rep       Date:  2011-07-21

Review 3.  Clinical implications of enteroadherent Escherichia coli.

Authors:  Margarita M P Arenas-Hernández; Ygnacio Martínez-Laguna; Alfredo G Torres
Journal:  Curr Gastroenterol Rep       Date:  2012-10

Review 4.  Travelers' Diarrhea: A Clinical Review.

Authors:  Alexander K C Leung; Amy A M Leung; Alex H C Wong; Kam L Hon
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

Review 5.  Immunization in travel medicine.

Authors:  Suzanne Moore Shepherd; William Hudson Shoff
Journal:  Prim Care       Date:  2011-12       Impact factor: 2.907

Review 6.  Chemoprophylaxis of Tropical Infectious Diseases.

Authors:  William J H McBride
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

7.  U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.

Authors:  Lorena M Coria; Franco L Martinez; Laura A Bruno; Karina A Pasquevich; Juliana Cassataro
Journal:  Vaccine       Date:  2020-06-11       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.